- Forums
- ASX - By Stock
- MSB
- Ann: FDA Accepts Mesoblast's BLA Resubmission for Remestemcel-L
Ann: FDA Accepts Mesoblast's BLA Resubmission for Remestemcel-L, page-34
Featured News
Add MSB (ASX) to my watchlist
|
|||||
Last
97.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.130B |
Open | High | Low | Value | Volume |
96.5¢ | 99.5¢ | 96.5¢ | $1.132M | 1.156M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
8 | 40829 | 97.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
97.5¢ | 51194 | 28 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
13 | 36063 | 0.975 |
14 | 151877 | 0.970 |
11 | 238734 | 0.965 |
10 | 84393 | 0.960 |
7 | 415178 | 0.955 |
Price($) | Vol. | No. |
---|---|---|
0.980 | 29956 | 23 |
0.985 | 191348 | 17 |
0.990 | 120902 | 19 |
0.995 | 230966 | 15 |
1.000 | 184785 | 17 |
Last trade - 11.53am 26/08/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
SER
STRATEGIC ENERGY RESOURCES LIMITED
David DeTata, Managing Director
David DeTata
Managing Director
SPONSORED BY The Market Online